Are you Dr. Van Ummersen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
765 Image Way
Orange City, FL 32763Phone+1 386-774-7411Fax+1 386-774-7412
Summary
- Dr. Lynn Van Ummersen, MD is an oncologist in Orange City, Florida. She is currently licensed to practice medicine in Florida, Illinois, and Wisconsin. She is affiliated with AdventHealth Fish Memorial and Central Florida Regional Hospital.
Education & Training
- Georgetown University HospitalFellowship, Medical Oncology, 1995 - 1997
- University of MarylandResidency, Internal Medicine, 1992 - 1994
- UMass Chan Medical SchoolInternship, Internal Medicine, 1991 - 1992
- University of Massachusetts Medical SchoolClass of 1991
Certifications & Licensure
- FL State Medical License 2007 - 2027
- WI State Medical License 1998 - 2007
- IL State Medical License 1998 - 2002
- DC State Medical License 1996 - 1998
- MD State Medical License 1994 - 1995
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Publications & Presentations
PubMed
- 8 citationsCapecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trialUchenna O. Njiaju, Amye J. Tevaarwerk, KyungMann Kim, J. E. Chang, R. M. Hansen
Cancer Chemotherapy and Pharmacology. 2013-03-01 - 177 citationsA phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metas...Eric J. Small, Michael A. Carducci, James M. Burke, Ronald Rodriguez, Lawrence Fong
Molecular Therapy. 2006-07-01 - 9 citationsPhase II study of interferon-alpha and doxycycline for advanced renal cell carcinomaMichael S. Huie, Kurt R. Oettel, Lynn Van Ummersen, Mann Kim Kyung, Yulin Zhang
Investigational New Drugs. 2006-05-01